Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Distinct Chromatin Accessibility Changes, Aberrant Transcription Factor Networks Combined with Novel Oncogenic Enhancers Characterise Myeloma-Initiating Genetic Events

Nikolaos Trasanidis, Jaime Alvarez-Benayas, Alexia Katsarou, Aristeidis Chaidos, Philippa C May, Kanagaraju Ponnusamy, Xiaolin Xiao, Marco Bua, MD, Maria Atta, MD, Irene Roberts, Holger W Auner, MD PhD, Evdoxia Hatjiharissi, Maria Papaioannou, Valentina S Caputo, Ian Sudbery, Anastasios Karadimitris

Blood (2019) 134 (Supplement_1): 1769.

https://doi.org/10.1182/blood-2019-124761

Published: 2019

Journal Articles

Archiving of Somatic Novel Mutations Using Whole-Exome Sequencing in Pakistani Myeloid Leukemic Patients

Abdul Rehman Khalil, MBBS, M.Phil, Arshi Naz, Ikramdin Ujjan, PhD MBBS, Tahir S. Shamsi, MBBS,FRCPath

Blood (2019) 134 (Supplement_1): 5167.

https://doi.org/10.1182/blood-2019-131688

Published: 2019

Journal Articles

Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity Selectively Targets Human Acute Myeloid Leukemia Stem Cells

Amit Subedi, PhD, Qiang Liu, PhD BSc, David Sharon, PhD, Changjiang Xu, Veronique Voisin, PhD, Gary D Bader, Jean Wang, MD, Steven M Chan, MD PhD

Blood (2018) 132 (Supplement 1): 3932.

https://doi.org/10.1182/blood-2018-99-120258

Published: 2018

Journal Articles

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Shelley Herbrich, MS, Peter P. Ruvolo, PhD, Vivian Ruvolo, PhD, Keith Baggerly, PhD, Gheath Alatrash, DO, PhD, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD

Blood (2017) 130 (Supplement 1): 3962.

https://doi.org/10.1182/blood.V130.Suppl_1.3962.3962

Published: 2017

Journal Articles

Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project

Alessandro Lagana, PhD, David Melnekoff, BS, MSc, Itai Beno, PhD, Violetta Leshchenko, PhD, Deepak Perumal, PhD, Jonathan J. Keats, PhD, Mary DeRome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, MD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2017) 130 (Supplement 1): 325.

https://doi.org/10.1182/blood.V130.Suppl_1.325.325

Published: 2017

Journal Articles

INPP4B is a Biomarker of Poor Prognosis in AML Which is Associated with EVI1 Overexpression and a LSC Signature

Irakli Dzneladze, BSc, John F Woolley, PhD, Youqi Han, PhD, Mark Sharobim, BSc, Ayesha Rashid, MSc, Michael D Jain, PhD MD, Mark D. Minden, MD PhD, Leonardo Salmena, PhD

Blood (2016) 128 (22): 3929.

https://doi.org/10.1182/blood.V128.22.3929.3929

Published: 2016

Journal Articles

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Lindsay M Morton, PhD, Graca M. Dores, MD MPH, Meredith S Shiels, PhD, Martha S Linet, MD MPH, Jop C Teepen, Clara J.K. Lam, PhD, Margaret A. Tucker, MD, Rochelle E Curtis, MA

Blood (2015) 126 (23): 562.

https://doi.org/10.1182/blood.V126.23.562.562

Published: 2015

Journal Articles

A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma

Kenneth H. Shain, MD PhD, Ariosto Silva, PhD, Mark B Meads, PhD, Allison Distler, B.S., Timothy Jacobson, B.S., Robert Gatenby, MD, PhD, Rachid Baz, Maria Silva, M.Sc, Dmitri Rebatchouk, PhD, Chris Cubitt, PhD

Blood (2015) 126 (23): 501.

https://doi.org/10.1182/blood.V126.23.501.501

Published: 2015

Journal Articles

Ex Vivo Expanded NK Cells Mediate Highly Efficient and Rapid Killing of Ewing Sarcoma Cells Through Degranulation with Tumor Cytotoxicity Controlled by the NKG2D, DNAM-1, and NKp30 NK Receptors

Amrita D. Karambelkar, B.S., Robert N. Reger, B.S., Mattias Carlsten, MD, PhD, Richard W. Childs, MD

Blood (2015) 126 (23): 1894.

https://doi.org/10.1182/blood.V126.23.1894.1894

Published: 2015

Journal Articles

Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing

Yuhuan Zheng, PhD, Qiang Wang, PhD, Jianfei Qian, PhD, Yi Li, MD, Yong Lu, PhD, Enguang Bi, PhD, Mingjun Zhang, PhD, Tianshu Li, PhD, Maojie Yang, MS, Yu Wu, MD PhD, Frederic J. Reu, MD, Zhen Cai, Qing Yi, MD PhD

Blood (2014) 124 (21): 2015.

https://doi.org/10.1182/blood.V124.21.2015.2015

Published: 2014

Journal Articles

Chemokines CCL14 and CCL3 Facilitate Monocytes/Macrophage Infiltration in Multiple Myeloma Bone Marrow

Yi Li, M.MD, Yuhuan Zheng, PhD, Li Yang, M.MD, Qiang Wang, PhD, Enguang Bi, PhD, Tianshu Li, PhD, Yong Lu, PhD, Jianfei Qian, PhD, Mingjun Zhang, PhD, Maojie Yang, MS, Qing Yi, MD PhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 3380.

https://doi.org/10.1182/blood.V124.21.3380.3380

Published: 2014

Journal Articles

The Novel Phospholipid Gemcitabine Conjugate KPC34 Has Activity In Acute Leukemia

Timothy Pardee, MD, PhD, Peter Alexander, BA, Kristin Stadelman, MS, Greg Kucera, PhD

Blood (2013) 122 (21): 1425.

https://doi.org/10.1182/blood.V122.21.1425.1425

Published: 2013

Journal Articles

Prognostic Significance Of Soft Tissue Involvement and International Prognostic Index In Primary Bone Lymphoma– A Single Institutional Experience

Huanwen Wu, MD, PhD, Marilyn Bui, MD, PHD, Haipeng Shao, MD, PhD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, William Bulkeley, MD, Ling Zhang, MD

Blood (2013) 122 (21): 1781.

https://doi.org/10.1182/blood.V122.21.1781.1781

Published: 2013

Journal Articles

Metabolomics Identifies Potential Biomarkers of Multiple Myeloma Development and Progression

Francesca Fontana, MD, PhD, Josè Manuel garcia Manteiga, PhD, Magda Marcatti, MD, Francesca Lorentino, MD, Giovanni Tonon, MD, PhD, Fabio Ciceri, MD, Roberto Sitia, MD, Simone Cenci, MD

Blood (2012) 120 (21): 3985.

https://doi.org/10.1182/blood.V120.21.3985.3985

Published: 2012

Journal Articles

Predicting Blood Loss and Transfusion Requirement in Patients Undergoing Surgery for Musculoskeletal Tumors

Philip A Thompson, MD, Deborah May, Peter Choong, Scott McArdle, Mary Gaskell, Gerard Powell, Danny Liew, Merrole Faye Cole-Sinclair

Blood (2012) 120 (21): 4384.

https://doi.org/10.1182/blood.V120.21.4384.4384

Published: 2012

Journal Articles

Myeloma Cells Exhibit Inhibitory Effect On Osteoclastogenesis

Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Haiyan Li, MD, PhD, Jingda Xu, PhD, Jin He, Eryong Huang, Yong Lu, PhD, Jungsun Park, Bangxing Hong, PhD, Mingjun Zhang, PhD, Jianfei Qian, PhD, Pei Lin, MD, Larry W. Kwak, MD, PhD, Qing Yi, MD, PhD, Jing Yang, PhD

Blood (2012) 120 (21): 439.

https://doi.org/10.1182/blood.V120.21.439.439

Published: 2012

Journal Articles

Altered Lipid and Mitochondrial Metabolism Are Viable Targets in Acute Leukemia,

Timothy Pardee, MD, PhD, Laura M DeFord-Watts, PhD, Erica Peronto, BS, Denise A Levitan, MD, David Duane Hurd, MD, Steven Kridel, PhD

Blood (2011) 118 (21): 3618.

https://doi.org/10.1182/blood.V118.21.3618.3618

Published: 2011

Journal Articles

Distribution of Bim Determines MCL-1 Dependence or Co-Dependence on BCL-x L /BCL-2 In Multiple Myeloma

Lawrence H. Boise, PhD, Alejo A Morales, PhD, Metin Kurtoglu, MD, PhD, Shannon M Matulis, PhD, Rebecca Markovitz, Kelvin P Lee, MD, Sagar Lonial, MD

Blood (2010) 116 (21): 4054.

https://doi.org/10.1182/blood.V116.21.4054.4054

Published: 2010

Journal Articles

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition.

Jeffrey R Gardner, BS, MBA, Mark Lawrence Heaney, MD, PhD, Linghao Niu, PhD

Blood (2009) 114 (22): 3618.

https://doi.org/10.1182/blood.V114.22.3618.3618

Published: 2009

Journal Articles

Bone Involvement in Lymphoma: 36 Cases. An Argentinian Cooperative Study.

Marta O Dragosky, MD, Susana Alcaraz, MD, Isabel Annetta, MD, Laura Devotto, MD, Ariel Corzo, MD, Patricia Luchetta, MD, Marisa Marquez, MD, Eduardo Morgenfeld, MD

Blood (2009) 114 (22): 5025.

https://doi.org/10.1182/blood.V114.22.5025.5025

Published: 2009

NARROW

Distinct Chromatin Accessibility Changes, Aberrant Transcription Factor Networks Combined with Novel Oncogenic Enhancers Characterise Myeloma-Initiating Genetic Events

Archiving of Somatic Novel Mutations Using Whole-Exome Sequencing in Pakistani Myeloid Leukemic Patients

Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity Selectively Targets Human Acute Myeloid Leukemia Stem Cells

Robust Bioinformatics Approach for Identifying Novel AML LSC Targets: Putative Role of Galectin-1 in the Immune-Microenvironment

Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project

INPP4B is a Biomarker of Poor Prognosis in AML Which is Associated with EVI1 Overexpression and a LSC Signature

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma

Ex Vivo Expanded NK Cells Mediate Highly Efficient and Rapid Killing of Ewing Sarcoma Cells Through Degranulation with Tumor Cytotoxicity Controlled by the NKG2D, DNAM-1, and NKp30 NK Receptors

Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing

Chemokines CCL14 and CCL3 Facilitate Monocytes/Macrophage Infiltration in Multiple Myeloma Bone Marrow

The Novel Phospholipid Gemcitabine Conjugate KPC34 Has Activity In Acute Leukemia

Prognostic Significance Of Soft Tissue Involvement and International Prognostic Index In Primary Bone Lymphoma– A Single Institutional Experience

Metabolomics Identifies Potential Biomarkers of Multiple Myeloma Development and Progression

Predicting Blood Loss and Transfusion Requirement in Patients Undergoing Surgery for Musculoskeletal Tumors

Myeloma Cells Exhibit Inhibitory Effect On Osteoclastogenesis

Altered Lipid and Mitochondrial Metabolism Are Viable Targets in Acute Leukemia,

Distribution of Bim Determines MCL-1 Dependence or Co-Dependence on BCL-x L /BCL-2 In Multiple Myeloma

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition.

Bone Involvement in Lymphoma: 36 Cases. An Argentinian Cooperative Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only